acut
viral
bronchiol
one
common
respiratori
diseas
earli
childhood
major
health
problem
worldwid
zorc
hall
season
burden
diseas
number
hospit
year
risk
subsequ
asthma
koponen
et
al
bring
substanti
cost
develop
countri
pelleti
et
al
respiratori
syncyti
viru
rsv
human
rhinoviru
hrv
seem
frequent
etiolog
agent
virus
human
metapneumoviru
hmpv
influenza
viru
iv
parainfluenza
viru
piv
also
involv
marguet
et
al
feuillet
et
al
spectrum
clinic
outcom
wide
bronchiol
sever
caus
rsv
marguet
et
al
contrast
hrv
involv
milder
form
like
associ
recurr
wheez
infanc
marguet
et
al
valkonen
et
al
gern
midulla
et
al
past
year
mani
signific
studi
focus
understand
patholog
respect
influenc
viru
larger
spectrum
outcom
remain
unclear
murin
model
human
rsv
diseas
viral
infect
shown
caus
major
inflamm
lead
epitheli
barrier
alter
bern
et
al
howev
result
experiment
studi
pathogenesi
specif
featur
bronchiol
alway
extend
human
host
specif
major
recent
clinic
studi
limit
conduct
select
popul
hospit
children
data
children
seen
outpati
kiening
regamey
koponen
et
al
like
potenti
sever
symptom
risk
wheez
explain
initi
epitheli
injuri
differ
inflammatori
cascad
depend
viru
involv
may
also
play
role
ioannidi
et
al
kreb
von
den
lungen
antigen
mucin
glycoprotein
first
describ
pulmonari
antigen
protein
normal
present
type
ii
pneumocyt
respiratori
bronchiolar
epitheli
cell
hirasawa
et
al
elev
serum
level
associ
increas
permeabl
barrier
serum
recent
shown
use
marker
sever
rsv
bronchiol
japan
kawasaki
et
al
thu
decid
perform
prospect
studi
popul
children
bronchiol
winter
epidem
season
assess
correl
clinic
sever
acut
bronchiol
serum
level
caus
virus
consecut
infant
acut
bronchiol
age
year
examin
pediatr
emerg
depart
esta
univers
hospit
franc
one
epidem
season
octob
may
consid
inclus
bronchiol
diagnos
presenc
recent
histori
upper
respiratori
tract
infect
follow
onset
respiratori
distress
cough
tachypnea
retract
diffus
crackl
wheez
auscult
accord
intern
recommend
diagnosi
manag
acut
bronchiol
subcommitte
diagnosi
manag
bronchiol
children
includ
suspect
confirm
underli
chronic
diseas
ie
cystic
fibrosi
chronic
pulmonari
diseas
congenit
heart
diseas
bronchopulmonari
diseas
prematur
alreadi
one
wheez
episod
detail
demograph
data
obtain
parent
structur
questionnair
studi
variabl
includ
age
gender
exposur
tobacco
smoke
famili
parent
sister
brother
person
histori
atopi
nurseri
attend
weight
vital
sign
heart
rate
respiratori
rate
tympan
temperatur
oxygen
satur
breath
ambient
air
measur
puls
record
emerg
room
infant
condit
classifi
mild
moder
sever
accord
sever
score
calcul
respiratori
rate
respiratori
effort
admiss
wainwright
et
al
patient
admit
hospit
inpati
group
basi
french
nation
guidelin
ana
link
age
week
major
deterior
gener
condit
apnoea
cyanosi
respiratori
rate
persist
gastrointestin
disord
compromis
hydrat
dehydr
weight
loss
atelectasi
detect
chest
radiograph
carri
clinic
sign
psychosoci
problem
infant
hospit
follow
data
record
protein
crp
day
oxygen
therapi
need
durat
respiratori
support
mechan
ventil
need
durat
stay
pediatr
intens
care
unit
picu
pediatr
depart
day
gastroenter
feed
parenter
nutrit
occurr
respiratori
complic
defin
secondari
pulmonari
infect
document
blood
sampl
chest
radiograph
andor
atelectasi
radiolog
find
review
pediatr
pulmonologist
occurr
acut
respiratori
distress
syndrom
death
also
record
infant
requir
hospit
outpati
group
care
home
parent
taught
chest
physiotherapi
reliev
nasal
obstruct
accord
french
recommend
ana
link
infant
age
month
enrol
anesthesia
consult
carri
plan
surgic
intervent
eg
surgeri
inguin
hernia
clubfoot
control
group
measur
level
blood
sampl
determin
process
time
blood
test
point
health
statu
evalu
complet
medic
includ
clinic
questionnair
children
previou
histori
pulmonari
diseas
ie
histori
wheez
episod
prior
inclus
cardiopulmonari
diseas
chronic
pulmonari
diseas
prematur
infecti
process
particularli
recent
histori
upper
lower
respiratori
tract
infect
exclud
nasopharyng
aspir
collect
either
emerg
room
within
first
h
follow
admiss
detect
respiratori
virus
detect
perform
prospect
polymeras
chain
reaction
pcr
use
respiratori
system
mw
rang
assay
craponn
franc
panel
virus
extract
sampl
screen
five
duplex
pcr
kit
influenza
ab
rsvhmpv
hcovhpiv
advhbov
rhino
evcc
virus
screen
includ
iv
b
rsv
b
hmpv
coronavirus
refer
collect
cov
piv
adenoviru
adv
bocaviru
bov
hrv
enterovirus
ev
hrv
ev
relat
close
picornavirus
differenti
assay
identif
genu
speci
type
perform
sequenc
genom
region
describ
previous
henquel
et
al
proteinas
k
mgml
total
nucleic
acid
extract
clinic
sampl
use
extract
autom
system
craponn
franc
elut
accord
manufactur
recommend
extract
sampl
ad
amplif
premix
duplex
detect
protocol
amplif
program
first
step
revers
transcript
ribonucl
acid
rna
target
common
respiratori
mw
kit
revers
perform
system
qiagen
venlo
netherland
follow
manufactur
specif
result
valid
posit
neg
control
cellular
cell
control
detect
simultan
hrvev
rhino
evcc
kit
valid
sampl
qualiti
whole
pcr
process
extract
amplif
viral
defin
posit
result
detect
one
viru
venou
blood
sampl
process
serum
deep
frozen
check
stabil
freez
period
assay
enzym
link
immunosorb
assay
refer
number
immulab
gmbh
kassel
germani
use
determin
serum
concentr
measur
perform
duplic
serum
per
measur
accord
manufactur
recommend
micropl
read
measur
absorb
nm
correct
wavelength
nm
calibr
curv
show
iuml
highest
point
minimum
detect
level
assay
iuml
accord
manufactur
determin
coeffici
variat
duplic
across
entir
concentr
rang
calibr
control
sampl
signific
interfer
observ
infant
parent
gave
written
inform
consent
infant
particip
studi
approv
local
ethic
committe
de
protect
de
personn
franc
post
clinic
trial
http
wwwclinicaltrialsgov
id
number
owe
origin
studi
lack
inform
literatur
concern
relationship
serum
diseas
sever
believ
would
difficult
give
priori
sampl
size
estim
accord
inclus
capac
previou
studi
carri
pediatr
emerg
depart
henquel
et
al
estim
subject
would
requir
show
signific
correl
coeffici
statist
comput
stata
stata
corp
colleg
station
tx
data
express
frequenc
associ
percentag
categor
data
mean
sd
median
interquartil
rang
quantit
paramet
test
type
error
set
princip
analysi
link
valu
sever
score
carri
use
spearman
correl
coeffici
secondari
analysi
compar
group
case
vs
control
hospit
ye
vs
viru
detect
ye
vs
categor
data
perform
use
test
appropri
differ
concern
continu
data
independ
group
studi
use
student
kruskal
walli
test
appropri
normal
verifi
test
homoscedast
evalu
test
analys
perform
statist
method
comparison
analysi
variou
viral
continu
variabl
perform
anova
test
use
marascuillo
categor
data
quantit
data
perform
signific
found
two
group
multivari
analysi
perform
use
logist
regress
hospit
depend
variabl
forward
select
method
logic
link
function
variabl
test
multivari
analysi
model
p
univari
analysi
shtatland
et
al
accord
clinic
signific
paramet
steyerberg
et
al
result
express
odd
ratio
or
confid
interv
ci
multivari
analysi
carri
adjust
age
respiratori
rate
consid
continu
variabl
two
hundr
infant
enrol
studi
group
boy
mean
age
onset
month
tabl
one
hundr
three
children
attend
nurseri
histori
eczema
expos
tobacco
smoke
famili
histori
atopi
case
bronchiol
classifi
mild
case
moder
sever
basi
wainwright
sever
score
statist
differ
sever
accord
age
nurseri
attend
histori
eczema
exposur
tobacco
smoke
famili
histori
atopi
mean
serum
valu
iuml
control
group
compris
infant
statist
differ
observ
case
control
group
term
age
gender
nurseri
attend
histori
eczema
exposur
tobacco
smoke
famili
histori
atopi
one
hundr
children
hospit
medic
examin
emerg
room
constitut
inpati
group
patient
requir
oxygen
therapi
mean
durat
day
mean
durat
stay
day
requir
gastroenter
feed
mean
durat
day
develop
respiratori
complic
hospit
atelectasi
chest
radiograph
document
secondari
pulmonari
infect
children
inpati
group
significantli
younger
outpati
month
vs
month
p
present
sever
form
bronchiol
accord
assess
use
wainwright
sever
score
p
significantli
lower
vs
p
factor
associ
diseas
sever
summar
tabl
ii
eleven
children
admit
pediatr
intens
care
unit
picu
requir
respiratori
support
six
ventil
one
mechan
ventil
three
significantli
younger
children
hospit
pediatr
depart
month
vs
p
higher
wainwright
sever
score
p
lower
vs
p
need
oxygen
therapi
longer
period
time
day
vs
p
mean
durat
hospit
stay
longer
day
vs
p
children
admit
picu
requir
enter
nutrit
statist
hospit
pediatr
depart
p
document
secondari
pulmonari
infect
frequent
patient
picu
n
vs
n
p
atelectasi
n
vs
n
p
acut
respiratori
distress
syndrom
death
record
hospit
signific
differ
found
crp
level
relat
variou
clinic
featur
nasopharyng
aspir
collect
perform
patient
tabl
iii
least
one
respiratori
viru
detect
sampl
singl
infect
detect
patient
two
virus
identifi
test
panel
patient
common
pathogen
rsv
found
sampl
follow
picornavirus
hrv
ev
found
sampl
hrv
found
sampl
henc
second
common
viru
involv
adv
bov
hmpv
piv
iv
viru
repres
viru
found
hrvev
strain
genotyp
base
sequenc
identifi
ev
coxsackievirus
hrv
distribut
follow
n
n
n
eleven
strain
could
assign
detect
mix
sequenc
suggest
doubl
hrv
infect
patient
detect
patient
common
rsv
hrv
n
three
virus
involv
patient
four
three
patient
five
one
signific
differ
level
p
found
case
mean
iuml
control
iuml
children
hospit
p
need
intens
care
p
serum
level
similar
irrespect
type
viru
p
correl
found
serum
level
diseas
sever
score
spearman
rank
correl
coeffici
p
fig
hospit
rate
p
durat
hospit
p
need
intens
care
p
correl
initi
sever
score
tabl
iv
predict
factor
hospit
moder
sever
bronchiol
accord
sever
score
p
high
respiratori
rate
p
presenc
srv
nasopharyng
sampl
p
absenc
hrv
p
differ
found
whether
present
p
older
age
higher
protect
factor
p
p
respect
similar
factor
found
protect
hospit
picu
p
p
respect
predict
factor
hospit
picu
occurr
respiratori
complic
p
absenc
hrv
p
predict
factor
hospit
older
age
higher
protect
factor
hospit
p
p
respect
equal
true
hospit
picu
p
p
respect
predict
factor
hospit
picu
higher
respiratori
rate
p
occurr
respiratori
complic
p
prospect
french
studi
infant
first
episod
acut
bronchiol
signific
differ
level
found
case
control
group
classifi
cluster
mucin
lung
tumor
protein
ishikawa
et
al
protein
express
predominantli
alveolar
type
ii
cell
respiratori
bronchiolar
epitheli
cell
bronchiolar
gland
serou
cell
high
serum
level
associ
barrier
dysfunct
shown
correl
indic
permeabl
nathani
et
al
measur
serum
level
wide
accept
diagnost
test
japan
monitor
activ
interstiti
lung
diseas
kobayashi
kitamura
kawas
et
al
kondo
et
al
seem
use
tool
monitor
interstiti
diseas
european
popul
horimasu
et
al
report
serum
measur
chronic
lung
diseas
newborn
ogihara
et
al
kim
et
al
children
kobayashi
et
al
appear
pediatr
journal
standard
upper
limit
concentr
group
children
diseas
imai
et
al
would
seem
therefor
degre
alveolar
damag
must
present
case
elev
serum
concentr
bronchiol
alveola
damag
explain
increas
alveolar
pressur
alveolar
hyperinfl
howev
result
present
suggest
acut
viral
bronchiol
previous
healthi
children
correl
immun
system
inflammatori
reaction
viral
aggress
rather
epitheli
injuri
support
recent
studi
small
sampl
hospit
patient
show
innat
immun
respons
invers
correl
diseas
sever
children
acut
rsv
hrv
lower
respiratori
tract
infect
garcia
et
al
rsv
infect
respiratori
epitheli
cell
enhanc
neutrophil
epitheli
adhes
activ
increas
cleavag
detach
epithelium
infect
viru
wang
et
al
rsv
infect
airway
epithelium
vitro
model
found
collin
melero
rhinovirus
infect
cultur
human
tracheal
bronchiolar
epitheli
cell
tracheal
submucos
gland
cell
alveolar
epitheli
cell
bind
intercellular
adhes
molecul
low
densiti
lipoprotein
receptor
produc
cytokin
jartti
korppi
kennedi
et
al
publish
histopatholog
studi
acut
rsv
diseas
avail
would
seem
symptom
caus
small
airway
obstruct
plug
compos
mucu
fibrin
cellular
debri
leukocyt
dead
bronchial
epitheli
cell
infiltr
compos
morphonuclear
cell
bern
et
al
alveolar
epitheli
injuri
clearli
present
interstiti
pneumonia
suggest
mechan
lead
respiratori
failur
relat
bronchiolar
obstruct
host
immun
respons
viru
interstiti
dysfunct
although
present
case
acut
respiratori
distress
syndrom
underli
alveolar
diseas
chronic
heart
diseas
polymorphonuclear
neutrophil
product
shown
play
import
role
inflammatori
respons
rsv
infect
et
al
correl
sever
first
acut
episod
bronchiol
studi
small
sampl
size
marguet
et
al
result
suggest
cytokin
play
key
role
partli
mediat
respiratori
tract
inflamm
elicit
acut
infect
eosinophil
degranul
product
may
also
play
role
pathogenesi
rsv
bronchiol
harrison
et
al
kim
et
al
found
involv
asthma
exacerb
mani
vitro
model
papadopoulo
et
al
tsuji
et
al
viral
infect
may
induc
eosinophil
chemoattract
releas
form
airway
epitheli
cell
eotaxin
particularli
atop
individu
papadopoulo
et
al
eosinophil
activ
involv
releas
eosinophil
granul
protein
neurotoxin
eosinophil
cation
protein
cysteinyl
leukotrien
cytolin
may
lead
airway
damag
assess
level
cytokin
product
particularli
nasopharyng
aspir
atop
patient
could
yield
signific
find
studi
releas
marker
cell
injuri
oxid
stress
molecul
cytokin
respiratori
tract
would
lead
better
understand
complex
interact
host
etiolog
viral
agent
bronchiol
kratzer
et
al
would
also
interest
investig
risk
develop
recurr
wheez
asthma
accord
caus
viru
releas
variou
cytokin
atop
statu
futur
work
whether
concomit
infect
increas
sever
bronchiol
matter
debat
one
studi
small
sampl
size
occurr
mechan
ventil
increas
dual
rsv
hmpv
infect
present
sempl
et
al
convers
result
present
studi
consist
french
studi
observ
dual
rsvrv
infect
addit
effect
sever
bronchiol
marguet
et
al
potenti
diseas
progress
led
worker
look
risk
factor
sever
bronchiol
main
clinic
predictor
hospit
evalu
sever
outpati
group
age
month
histori
prematur
oxygen
satur
high
respiratori
rate
infant
age
sever
retract
sign
abnorm
chest
radiograph
result
zorc
hall
need
supplement
oxygen
without
intraven
fluid
greatest
influenc
far
rank
reliabl
predictor
durat
hospit
stay
wainwright
et
al
corn
et
al
link
result
present
agreement
find
confirm
clinic
tool
requir
identif
previous
healthi
children
risk
develop
acut
respiratori
insuffici
strong
point
studi
hospit
children
outpati
appli
protocol
respiratori
viru
detect
epitheli
dysfunct
analysi
includ
signific
virus
current
associ
bronchiol
studi
howev
limit
studi
deserv
mention
first
studi
result
need
confirm
larger
popul
sampl
secondli
patient
requir
picu
hospit
mechan
ventil
howev
previou
studi
perform
japan
kawasaki
et
al
seven
case
requir
artifici
respir
thu
discrep
observ
result
fulli
explain
may
due
differ
inclus
criteria
japanes
studi
probabl
allow
inclus
far
subject
interstiti
diseas
children
underli
congenit
heart
diseas
mechan
epitheli
injuri
like
differ
case
acut
bronchiol
infant
without
underli
diseas
anoth
limit
perform
bacteriolog
analysi
lower
airway
secret
could
introduc
bia
sinc
high
incid
pulmonari
bacteri
sever
rsv
bronchiol
document
elsewher
thorburn
et
al
howev
patient
popul
studi
thorburn
et
al
differ
includ
sever
case
requir
mechan
ventil
sampl
obtain
aspir
endotrach
tube
obtain
aspir
lower
airway
secret
invas
procedur
perform
good
qualiti
result
children
intub
moreov
recent
studi
perform
larg
cohort
conclud
seriou
bacteri
infect
appear
occur
infrequ
children
hospit
rsv
bronchiol
garcia
et
al
find
prospect
studi
french
infant
hospit
first
episod
acut
bronchiol
indic
respiratori
infect
clinic
entiti
associ
variou
viral
antigen
result
suggest
clinic
sever
bronchiol
correl
serum
level
previous
healthi
children
indic
variou
clinic
outcom
depend
adapt
capac
host
rather
intens
epitheli
dysfunct
highlight
fact
mani
featur
bronchiol
directli
affect
comorbid
underli
ill
treatment
oxygen
therapi
mechan
ventil
use
comput
score
respiratori
rate
chest
retract
sign
could
great
use
help
diagnos
infant
acut
bronchiol
treat
effect
